Recruiting
HER2-positive Breast Cancer Registry
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
ClinicalTrials.gov IDNCT06603597
PhaseNot Applicable
Enrollment1000
SponsorPriyanka Sharma
Age18 Years and older
SexALL
Conditions studied
HER2 + Breast Cancer
About this study
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Primary outcomes
- Overall survival rate (From diagnosis to 5 years after diagnosis)
Eligibility information
Inclusion Criteria:
* Stage I-IV HER2-positive breast cancer
Exclusion Criteria:
* None
Study locations
- KUCC - Indian Creek, Overland Park, Kansas 66211 United States
- KUCC - Overland Park, Overland Park, Kansas 66215 United States
- KUCC - Briarcliff, Westwood, Kansas 66205 United States
- KUCC - Olathe, Westwood, Kansas 66205 United States
- The University of Kansas Cancer Center, Westwood, Kansas 66205 United States
- KUCC - Lee's Summit, Lee's Summit, Missouri 64064 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-28.